According to a recent study, postnatal depression affects up to 15% of women and can have detrimental effects on both mothers and their children. However, only a small percentage of women with the condition in the UK receive treatment in the form of selective serotonin reuptake inhibitors (SSRIs), a type of antidepressant. The study, conducted by researchers from King’s College London, analyzed data from over 61,000 mothers and their children. Out of the mothers, 8,671 were diagnosed with postnatal depression, and 177 of them received SSRI treatment.
The findings of the study suggest that children whose mothers received SSRIs were less likely to exhibit behavioral difficulties and antisocial behavior by the age of five. Additionally, these children showed reduced symptoms of attention deficit hyperactivity disorder (ADHD). The mothers themselves also experienced reduced depression and increased satisfaction in their relationships with their partners compared to women who did not receive SSRIs.
Dr. Kate Liu, the first author of the study, emphasized that the low rate of SSRI treatment for postnatal depression in the UK is due to a lack of awareness of the condition and concerns about potential long-term effects on child development. However, this study provides evidence that postnatal SSRI treatment does not pose an increased risk to child development and actually helps reduce maternal depression and child behavioral difficulties.
Dr. Tom McAdams, senior author of the study, stressed the importance of recognizing and properly treating postnatal depression, viewing it as a severe mental illness and addressing it to mitigate negative outcomes for mothers, children, and families. SSRIs are believed to work by increasing serotonin levels in the brain and are typically taken in tablet form.
Overall, this study highlights the potential benefits of SSRI treatment for postnatal depression, improving mental health, relationships, and the behavior of children. The findings underscore the importance of increasing awareness and understanding of postnatal depression to ensure appropriate and effective treatment options are available to women in need.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
